Allosteric coupling from G protein to the agonist binding pocket in GPCRs

[1]  Stephen M. Husbands,et al.  Structural insights into μ-opioid receptor activation , 2015, Nature.

[2]  B. Krumm,et al.  Structural prerequisites for G-protein activation by the neurotensin receptor , 2015, Nature Communications.

[3]  Vadim Cherezov,et al.  Allosteric sodium in class A GPCR signaling. , 2014, Trends in biochemical sciences.

[4]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[5]  K. Garcia,et al.  Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.

[6]  Jonathan R. Tomshine,et al.  Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.

[7]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[8]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[9]  Virgil L. Woods,et al.  Conformational changes in the G protein Gs induced by the β2 adrenergic receptor , 2011, Nature.

[10]  Tong Liu,et al.  Structural flexibility of the Gαs α-helical domain in the β2-adrenoceptor Gs complex , 2011, Proceedings of the National Academy of Sciences.

[11]  Albert C. Pan,et al.  Pathway and mechanism of drug binding to G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.

[12]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[13]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[14]  Cheng Zhang,et al.  Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.

[15]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[16]  L. Pardo,et al.  Ligand-specific regulation of the extracellular surface of a G protein coupled receptor , 2009, Nature.

[17]  S. Rasmussen,et al.  The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex , 2009, Proceedings of the National Academy of Sciences.

[18]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[19]  D. Bylund,et al.  A robust GTP-induced shift in α2-adrenoceptor agonist affinity in tissue sections from rat brain , 2001, Journal of Neuroscience Methods.

[20]  T. Kenakin,et al.  The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy. , 1996, Journal of theoretical biology.

[21]  P. Morgan,et al.  The Cubic Ternary Complex ReceptorOccupancy Model I. Model Description , 1996 .

[22]  A. Gilman,et al.  Purification of Recombinant G Proteins from Sf9 Cells by Hexahistidine Tagging of Associated Subunits , 1995, The Journal of Biological Chemistry.

[23]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[24]  J. Linden,et al.  Indirect effect of guanine nucleotides on antagonist binding to A1 adenosine receptors: occupation of cryptic binding sites by endogenous vesicular adenosine. , 1992, Molecular pharmacology.

[25]  B. Cox,et al.  Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. , 1988, Molecular pharmacology.

[26]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[27]  R. Lefkowitz,et al.  Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Giudicelli,et al.  Catecholamine binding to the α-adrenergic receptors of hamster adipocytes evidence that guanine nucleotides regulate this binding to the α2-receptor subtype , 1982 .

[29]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[30]  M. Maguire,et al.  Relationship between the beta-adrenergic receptor and adenylate cyclase. , 1977, The Journal of biological chemistry.

[31]  R. Lefkowitz,et al.  Catecholamine binding to the beta-adrenergic receptor. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Maguire,et al.  An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. , 1976, Molecular pharmacology.

[33]  H. Horiuchi.  Seven-transmembrane receptors , 2015 .

[34]  Robert,et al.  A Mutation-induced Activated State of the ,&-Adrenergic Receptor EXTENDING THE TERNARY COMPLEX MODEL* , 2001 .

[35]  H. Kikkawa,et al.  The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. , 1998, Molecular pharmacology.

[36]  S R Sprang,et al.  G protein mechanisms: insights from structural analysis. , 1997, Annual review of biochemistry.